97 related articles for article (PubMed ID: 29703843)
1. MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder Cancer.
Koutsioumpa M; Chen HW; O'Brien N; Koinis F; Mahurkar-Joshi S; Vorvis C; Soroosh A; Luo T; Issakhanian S; Pantuck AJ; Georgoulias V; Iliopoulos D; Slamon DJ; Drakaki A
Mol Cancer Ther; 2018 Jul; 17(7):1430-1440. PubMed ID: 29703843
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1.
Monoe Y; Jingushi K; Kawase A; Hirono T; Hirose R; Nakatsuji Y; Kitae K; Ueda Y; Hase H; Abe Y; Adachi J; Tomonaga T; Tsujikawa K
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947152
[TBL] [Abstract][Full Text] [Related]
3. miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition.
Yang J; Yuan D; Li J; Zheng S; Wang B
Tumour Biol; 2016 Apr; 37(4):4331-41. PubMed ID: 26494000
[TBL] [Abstract][Full Text] [Related]
4. miR-892a regulated PPP2R2A expression and promoted cell proliferation of human colorectal cancer cells.
Liang WL; Cao J; Xu B; Yang P; Shen F; Sun Z; Li WL; Wang Q; Liu F
Biomed Pharmacother; 2015 May; 72():119-24. PubMed ID: 26054685
[TBL] [Abstract][Full Text] [Related]
5. miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells.
Zeng LP; Hu ZM; Li K; Xia K
J Cell Mol Med; 2016 Mar; 20(3):559-67. PubMed ID: 26800397
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of miR-556-5p promoted prostate cancer cell proliferation by suppressing PPP2R2A expression.
Zhao W; Cao L; Zeng S; Qin H; Men T
Biomed Pharmacother; 2015 Oct; 75():142-7. PubMed ID: 26297546
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA CEP128 promotes bladder cancer progression by regulating Mir-145-5p/Myd88 via MAPK signaling pathway.
Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
Int J Cancer; 2019 Oct; 145(8):2170-2181. PubMed ID: 30939216
[TBL] [Abstract][Full Text] [Related]
8. Benzyl isothiocyanate promotes miR-99a expression through ERK/AP-1-dependent pathway in bladder cancer cells.
Tsai TF; Chen PC; Lin YC; Chou KY; Chen HE; Ho CY; Lin JF; Hwang TI
Environ Toxicol; 2020 Jan; 35(1):47-54. PubMed ID: 31587482
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-136 Promotes Vascular Muscle Cell Proliferation Through the ERK1/2 Pathway by Targeting PPP2R2A in Atherosclerosis.
Zhang CF; Kang K; Li XM; Xie BD
Curr Vasc Pharmacol; 2015; 13(3):405-12. PubMed ID: 25409743
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.
Yan H; Ren S; Lin Q; Yu Y; Chen C; Hua X; Jin H; Lu Y; Zhang H; Xie Q; Huang C; Huang H
FASEB J; 2019 Nov; 33(11):12112-12123. PubMed ID: 31373842
[TBL] [Abstract][Full Text] [Related]
11. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
[TBL] [Abstract][Full Text] [Related]
12. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J
Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567
[TBL] [Abstract][Full Text] [Related]
13. Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo.
Zeng X; Xu Z; Gu J; Huang H; Gao G; Zhang X; Li J; Jin H; Jiang G; Sun H; Huang C
Mol Cancer Ther; 2016 Mar; 15(3):512-22. PubMed ID: 26832795
[TBL] [Abstract][Full Text] [Related]
14. Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145.
Jiang G; Huang C; Li J; Huang H; Jin H; Zhu J; Wu XR; Huang C
Mol Cancer Ther; 2017 May; 16(5):924-935. PubMed ID: 28223425
[TBL] [Abstract][Full Text] [Related]
15. miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR.
Xu C; Zeng Q; Xu W; Jiao L; Chen Y; Zhang Z; Wu C; Jin T; Pan A; Wei R; Yang B; Sun Y
Mol Cancer Ther; 2013 Feb; 12(2):207-19. PubMed ID: 23270926
[TBL] [Abstract][Full Text] [Related]
16. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
Zeng B; Shi W; Tan G
BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer.
Guo R; Gu J; Zhang Z; Wang Y; Gu C
IUBMB Life; 2015 Jan; 67(1):42-53. PubMed ID: 25646808
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5.
Xu T; Qin L; Zhu Z; Wang X; Liu Y; Fan Y; Zhong S; Wang X; Zhang X; Xia L; Zhang X; Xu C; Shen Z
Oncotarget; 2016 May; 7(19):27445-57. PubMed ID: 27050274
[TBL] [Abstract][Full Text] [Related]
20. microRNA-495 promotes bladder cancer cell growth and invasion by targeting phosphatase and tensin homolog.
Tan M; Mu X; Liu Z; Tao L; Wang J; Ge J; Qiu J
Biochem Biophys Res Commun; 2017 Feb; 483(2):867-873. PubMed ID: 28069380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
